Karl H Kraus1, Carl Kirker-Head. 1. Orthopedic Research Laboratory, Tufts Cummings School of Veterinary Medicine, North Grafton, MA 01536, USA. Karl.Kraus@Tufts.edu
Abstract
OBJECTIVE: To review the role of mesenchymal stem cells (MSC) in bone formation and regeneration, and outline the development of strategies that use MSC in bone healing and regeneration. STUDY DESIGN: Literature review. METHODS: Medline review, synopses of authors' published research. RESULTS: The MSC is the basic cellular unit of embryologic bone formation. Secondary bone healing mimics bone formation with proliferation of MSC then their differentiation into components of fracture callus. Bone regeneration, where large amounts of bone must form, mimics bone healing and can be achieved with MSC combined with strategies of osteogenesis, osteoinduction, osteoconduction, and osteopromotion. MSC based strategies first employed isolated and culture expanded stem cells in an osteoconductive carrier to successfully regenerate a critical segmental defect in the femur of dogs, which was as effective as autogenous cancellous bone. Because MSC appeared to be immunologically privileged, a study using mismatched allogeneic stem cells demonstrated that these cells would regenerate bone without inciting an immunologic response, documenting the possibility of banked allogeneic MSC for bone regeneration. A technique was developed for selectively retaining MSC from large bone marrow aspirates at surgery for bone regeneration. These techniques utilized osteoconductive and osteoinductive carriers and resulted in bone regeneration that was similar to autogenous cancellous bone. CONCLUSION: MSC can be manipulated and combined with carriers that will result in bone regeneration of critically sized bone defects. CLINICAL RELEVANCE: These techniques can be employed clinically to regenerate bone and serve as an alternative to autogenous cancellous bone.
OBJECTIVE: To review the role of mesenchymal stem cells (MSC) in bone formation and regeneration, and outline the development of strategies that use MSC in bone healing and regeneration. STUDY DESIGN: Literature review. METHODS: Medline review, synopses of authors' published research. RESULTS: The MSC is the basic cellular unit of embryologic bone formation. Secondary bone healing mimics bone formation with proliferation of MSC then their differentiation into components of fracture callus. Bone regeneration, where large amounts of bone must form, mimics bone healing and can be achieved with MSC combined with strategies of osteogenesis, osteoinduction, osteoconduction, and osteopromotion. MSC based strategies first employed isolated and culture expanded stem cells in an osteoconductive carrier to successfully regenerate a critical segmental defect in the femur of dogs, which was as effective as autogenous cancellous bone. Because MSC appeared to be immunologically privileged, a study using mismatched allogeneic stem cells demonstrated that these cells would regenerate bone without inciting an immunologic response, documenting the possibility of banked allogeneic MSC for bone regeneration. A technique was developed for selectively retaining MSC from large bone marrow aspirates at surgery for bone regeneration. These techniques utilized osteoconductive and osteoinductive carriers and resulted in bone regeneration that was similar to autogenous cancellous bone. CONCLUSION: MSC can be manipulated and combined with carriers that will result in bone regeneration of critically sized bone defects. CLINICAL RELEVANCE: These techniques can be employed clinically to regenerate bone and serve as an alternative to autogenous cancellous bone.
Authors: C Kirker-Head; V Karageorgiou; S Hofmann; R Fajardo; O Betz; H P Merkle; M Hilbe; B von Rechenberg; J McCool; L Abrahamsen; A Nazarian; E Cory; M Curtis; D Kaplan; L Meinel Journal: Bone Date: 2007-04-27 Impact factor: 4.398
Authors: Liliana F Mellor; Mahsa Mohiti-Asli; John Williams; Arthi Kannan; Morgan R Dent; Farshid Guilak; Elizabeth G Loboa Journal: Tissue Eng Part A Date: 2015-07-13 Impact factor: 3.845
Authors: Jaymi T Taiani; Roman J Krawetz; Nicole I Zur Nieden; Yiru Elizabeth Wu; Michael S Kallos; John R Matyas; Derrick E Rancourt Journal: Stem Cells Dev Date: 2010-07 Impact factor: 3.272
Authors: Byung Jun Jang; Ye Eun Byeon; Ji Hey Lim; Hak Hyun Ryu; Wan Hee Kim; Yoshihisa Koyama; Masanori Kikuchi; Kyung Sun Kang; Oh Kyeong Kweon Journal: J Vet Sci Date: 2008-12 Impact factor: 1.672